INS and Hyperglycemia: Among the hepatokines, selenoprotein P (SeP, encoded by SELENOP in humans) is upregulated in the diabetic state with hyperglycemia and reduced insulin action and plays a role in diabetic pathology such as insulin resistance in the liver and exercise resistance in the skeletal muscle by eliminating the reactive oxygen species required for signal transduction [4, 5].